Engineering Tumor-Targeting T-Cells to Overcome the Tolerance Barriers in Cancer Treatment
Time: 2:00 pm
day: Conference Day Two - Track A - PM
Details:
- Exploring genetic-enhancing modifiers (GEMs) as a platform to modify TIL function and the TME
- Enhancing TIL killing and persistence in the TME through modulation
